NEXENTIS TECHNOLOGIES INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
NEXENTIS TECHNOLOGIES INC. (NXTS) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $1.78 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $1.78M.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $12.86M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $15.73M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $8.68M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-06-30 | $1.78M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $12.86M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $15.73M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $8.68M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $5.55M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $3.70M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $4.57M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $5.30M 10-Q · filed 2025-11-13 | $5.30M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $5.89M 10-Q · filed 2025-11-13 | $5.89M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $5.70M 10-Q · filed 2025-11-13 | $5.70M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $6.46M 10-K · filed 2026-03-31 | $6.46M 10-K · filed 2024-04-01 |
| 2023-09-30 | $4.62M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $5.56M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $4.77M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $5.74M 10-K · filed 2025-03-31 | $5.74M 10-K · filed 2023-03-27 |
| 2022-09-30 | $7.02M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $4.39M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $5.36M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $6.41M 10-K · filed 2024-04-01 | |
| 2021-09-30 | $7.83M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $8.92M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | -$875.25K 10-Q · filed 2022-11-14 | |
| 2020-12-31 | -$465.45K 10-K · filed 2023-03-27 | |
| 2020-09-30 | -$370.93K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | -$412.07K 10-Q · filed 2021-11-15 | |
| 2020-03-31 | -$701.08K 10-Q · filed 2021-11-15 | |
| 2019-12-31 | -$402.12K 10-K · filed 2022-03-31 | |
| 2019-09-30 | -$125.26K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $210.96K 10-Q · filed 2020-08-11 | |
| 2019-03-31 | $376.79K 10-Q · filed 2020-05-15 | |
| 2018-12-31 | $211.51K 10-K · filed 2021-03-29 | |
| 2017-12-31 | -$743.46K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |